Pluri (PLUR) Gross Profit Growth (1y) (2012 - 2025)
Pluri (PLUR) Gross Profit Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 126.09% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 33.01% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 57.16% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -99.98% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 351.57% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -22.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.52% |
| Sep 30, 2025 | -42.50% |
| Jun 30, 2025 | 125.00% |
| Mar 31, 2025 | 91.55% |
| Dec 31, 2024 | 5.71% |
| Sep 30, 2024 | 270.37% |
| Dec 31, 2019 | -54.17% |
| Dec 31, 2018 | 0.00% |
| Dec 31, 2015 | 2,817.58% |
| Sep 30, 2015 | 0.00% |
| Dec 31, 2014 | -1.09% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | -1.08% |
| Mar 31, 2014 | -51.06% |
| Dec 31, 2013 | -51.32% |
| Sep 30, 2013 | -51.32% |
| Jun 30, 2013 | -5.10% |
| Mar 31, 2013 | -16.07% |
| Dec 31, 2012 | 84,275.00% |
| Sep 30, 2012 | 26.85% |